We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LJPC
751
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $623K | 0.01% |
154,650
+48,004
| +45% | +$199K |
|
752
Wendy's
WEN
$1.46B
| $606K | 0.01% |
+27,180
| New | +$599K |
|
753
SFL Corp
SFL
$1.61B
| $602K | 0.01% |
80,424
-38,408
| -32% | -$336K |
|
|
LGTY
754
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $595K | 0.01% |
42,401
-890
| -2% | -$13.9K |
|
|
CSLT
755
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $594K | 0.01% |
526,026
-289,078
| -35% | -$318K |
|
756
Exelon
EXC
$48.1B
| $593K | 0.01% |
23,235
-23,095
| -50% | -$612K |
|
|
ISEE
757
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $587K | 0.01% |
104,126
-32,956
| -24% | -$157K |
|
758
J.M. Smucker
SJM
$13.5B
| $586K | 0.01% |
5,076
+2,033
| +67% | +$227K |
|
|
PCSB
759
DELISTED
PCSB Financial Corporation
PCSB
| $584K | 0.01% |
48,394
-14,569
| -23% | -$179K |
|
760
Sterling Infrastructure
STRL
$15.2B
| $583K | 0.01% |
41,207
| – | – |
|
761
Northrim BanCorp
NRIM
$593M
| $576K | 0.01% |
90,316
-12,544
| -12% | -$78.4K |
|
|
LOGC
762
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $574K | 0.01% |
63,221
+51,719
| +450% | +$392K |
|
763
Camping World
CWH
$384M
| $573K | 0.01% |
+19,263
| New | +$629K |
|
|
FARM
764
DELISTED
Farmer Brothers
FARM
| $572K | 0.01% |
129,447
-13,771
| -10% | -$81.7K |
|
|
TSC
765
DELISTED
TriState Capital Holdings, Inc.
TSC
| $569K | 0.01% |
42,979
-8,345
| -16% | -$117K |
|
766
GameStop
GME
$9.8B
| $560K | 0.01% |
219,704
-1,397,640
| -86% | -$2.02M |
|
767
Elastic
ESTC
$6.7B
| $558K | 0.01% |
5,173
-12,860
| -71% | -$1.26M |
|
768
Fortress Biotech
FBIO
$111M
| $557K | 0.01% |
9,194
-178
| -2% | -$9.07K |
|
769
Piper Sandler
PIPR
$4.99B
| $555K | 0.01% |
+30,392
| New | +$518K |
|
|
SWTX
770
DELISTED
SpringWorks Therapeutics
SWTX
| $550K | 0.01% |
+11,528
| New | +$491K |
|
771
Financial Institutions
FISI
$812M
| $543K | 0.01% |
35,274
-8,980
| -20% | -$147K |
|
772
The GEO Group
GEO
$4B
| $543K | 0.01% |
+47,890
| New | +$534K |
|
773
Babcock & Wilcox
BW
$1.18B
| $541K | 0.01% |
233,129
+55,290
| +31% | +$138K |
|
|
SYRS
774
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $540K | 0.01% |
6,109
-633
| -9% | -$71.9K |
|
|
DFS
775
DELISTED
Discover Financial Services
DFS
| $539K | 0.01% |
9,332
| – | – |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.